Chemoinformaics analysis of 2-AMINOOXYPHENOL
| Molecular Weight | 125.127 | nRot | 1 |
| Heavy Atom Molecular Weight | 118.071 | nRig | 14 |
| Exact Molecular Weight | 125.048 | nRing | 1 |
| Solubility: LogS | -4.195 | nHRing | 0 |
| Solubility: LogP | 2.528 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 16 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 17.3916 |
| nHD | 2 | BPOL | 7.04845 |
| QED | 0.482 |
| Synth | 2.381 |
| Natural Product Likeliness | 0.775 |
| NR-PPAR-gamma | 0.024 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.012 |
| Pgp-sub | 0.027 |
| HIA | 0.005 |
| CACO-2 | -4.667 |
| MDCK | 0.0000202 |
| BBB | 0.036 |
| PPB | 0.821402 |
| VDSS | 0.705 |
| FU | 0.0974883 |
| CYP1A2-inh | 0.963 |
| CYP1A2-sub | 0.955 |
| CYP2c19-inh | 0.77 |
| CYP2c19-sub | 0.306 |
| CYP2c9-inh | 0.57 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.485 |
| CYP2d6-sub | 0.861 |
| CYP3a4-inh | 0.298 |
| CYP3a4-sub | 0.446 |
| CL | 10.658 |
| T12 | 0.739 |
| hERG | 0.09 |
| Ames | 0.175 |
| ROA | 0.079 |
| SkinSen | 0.259 |
| Carcinogencity | 0.791 |
| EI | 0.972 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.126 |
| Antiviral | No |
| Prediction | 0.89696 |